BIOLASE, Inc. (NASDAQ: BIOL) is a medical device company specializing in the development, manufacture and sale of laser-based systems for dental and medical applications. The company’s flagship offerings include all-tissue laser platforms such as the Waterlase® family, which combine laser energy with a stream of water to perform cutting, debridement and other clinical procedures with reduced pain and enhanced healing. In addition to all-tissue systems, BIOLASE markets diode-based laser devices for soft‐tissue surgery, periodontal therapy, endodontics and teeth whitening, along with a range of accessories and consumables designed to optimize clinical performance and patient outcomes.
BIOLASE’s product portfolio extends beyond hardware to encompass software-driven treatment protocols, training programs and digital imaging integration, supporting dental professionals in expanding their clinical capabilities. The company operates a comprehensive service network that provides installation, maintenance and technical support, as well as on‐site and online education for practitioners. Through a combination of direct sales and distribution partnerships, BIOLASE reaches private practices, group practices, academic institutions and government facilities worldwide.
Founded in the early 1980s, BIOLASE initially focused on the research and commercialization of medical lasers before pivoting its efforts toward dental applications in the early 2000s. The company went public in the 1990s and has since broadened its presence through strategic acquisitions and international expansion. BIOLASE’s headquarters are located in Irvine, California, and its operations span North America, Europe, Asia-Pacific and Latin America, with regional offices and authorized distributors in key markets such as Germany, Japan, China and Brazil.
BIOLASE is overseen by a board of directors and led by an experienced executive team with deep expertise in medical technology, regulatory affairs and global commercialization. The senior leadership remains focused on advancing laser dentistry through ongoing research and development, expanding the installed base of clinical systems and enhancing customer support programs. By emphasizing innovation, clinical education and strategic partnerships, BIOLASE aims to drive long-term adoption of laser therapies in dental and medical specialties around the world.
AI Generated. May Contain Errors.
Free BIOL Stock Alerts